Abstract

Osteoarthritis (OA) is a common chronic disease and a significant health concern that needs to be urgently solved. OA affects the cartilage and entire joint tissues, including the subchondral bone, synovium, and infrapatellar fat pads. The physiological and pathological changes in these tissues affect the occurrence and development of OA. Understanding complex crosstalk among different joint tissues and their roles in OA initiation and progression is critical in elucidating the pathogenic mechanism of OA. In this review, we begin with an overview of the role of chondrocytes, synovial cells (synovial fibroblasts and macrophages), mast cells, osteoblasts, osteoclasts, various stem cells, and engineered cells (induced pluripotent stem cells) in OA pathogenesis. Then, we discuss the various mechanisms by which these cells communicate, including paracrine signaling, local microenvironment, co-culture, extracellular vesicles (exosomes), and cell tissue engineering. We particularly focus on the therapeutic potential and clinical applications of stem cell-derived extracellular vesicles, which serve as modulators of cell-to-cell communication, in the field of regenerative medicine, such as cartilage repair. Finally, the challenges and limitations related to exosome-based treatment for OA are discussed. This article provides a comprehensive summary of key cells that might be targets of future therapies for OA.

Highlights

  • Osteoarthritis (OA) is a common degenerative disease of the joints that causes chronic pain and motor dysfunction and affects the quality of life of more than 300 million people worldwide (GBD 2017 Risk Factor Collaborators, 2018)

  • Because patients with OA are prone to complications, inappropriate drug treatment and multidrug therapy can increase the risk of side effects (Gore et al, 2011)

  • In a destabilization of the medial meniscus (DMM)-induced OA mouse model, exosomes derived from Infrapatellar fat pad (IPFP) Mesenchymal stem cells (MSCs) effectively reduced cartilage damage and improved abnormal gait

Read more

Summary

Introduction

Osteoarthritis (OA) is a common degenerative disease of the joints that causes chronic pain and motor dysfunction and affects the quality of life of more than 300 million people worldwide (GBD 2017 Risk Factor Collaborators, 2018). EVs protected chondrocytes (Headland et al, 2015) and regulated the physiological activities of various types of immune cells (Lo Sicco et al, 2017), indicating their anti-inflammatory effects. Therapeutic Potential of Stem Cell-Derived Exosomes in OA Stem cells, such as BMSCs and AMSCs, promote cartilage regeneration and have been used in clinical trials for OA treatment (Lee and Wang, 2017; De Bari and Roelofs, 2018).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call